These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3172816)

  • 1. Expression of a leukemia-associated antigen (CAMAL) in four myeloid leukemia cell lines.
    Shipman RC; Levy JG
    Leuk Res; 1988; 12(7):537-43. PubMed ID: 3172816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
    Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
    Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a common leukemia-associated antigen in human myelogenous leukemia using immunoperoxidase.
    Logan PM; Malcolm AJ; Levy JG
    Diagn Immunol; 1984; 2(2):86-100. PubMed ID: 6238754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.
    Posner MR; Santos DJ; Elboim HS; Tumber MB; Frackelton AR
    Cancer Res; 1989 Apr; 49(7):1665-70. PubMed ID: 2924315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAMAL: a new prognostic marker for remission in acute nonlymphoblastic leukemia.
    Logan PM; Whitney S; Naiman S; Levy JG
    Leuk Res; 1988; 12(1):19-24. PubMed ID: 3282127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine hematopoiesis by CAMAL, an inhibitor of human hematopoiesis.
    Leitch HA; Yip ST; Jamieson CH; Levy JG
    Leukemia; 1993 May; 7(5):717-24. PubMed ID: 8483324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAMAL: evidence for an inhibitory role in normal granulopoiesis.
    Logan PM; Shellard J; Buskard N; Levy JG
    Exp Hematol; 1989 Dec; 17(11):1072-6. PubMed ID: 2684678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
    Malcolm AJ; Shipman RC; Logan PM; Levy JG
    Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation.
    Mew D; Lum V; Wat CK; Towers GH; Sun CH; Walter RJ; Wright W; Berns MW; Levy JG
    Cancer Res; 1985 Sep; 45(9):4380-6. PubMed ID: 4028022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional analysis of metabolically and cell surface radiolabeled proteins of some human lymphoid and myeloid leukemia cell lines. I. 35S-methionine labeled, lactoperoxidase radioiodinated and 3H-reductively methylated proteins.
    Duraj J; Chorváth B; Sedlák J; Plesková I
    Neoplasma; 1986; 33(5):555-64. PubMed ID: 3466043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of leukemic myelopoiesis by P30-35 CAMAL, an inhibitor of normal myelopoiesis.
    Leitch HA; Buskard N; Levy JG
    Leukemia; 1993 Sep; 7(9):1394-401. PubMed ID: 8371590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on CD11a and CD18 molecules with two new monoclonal antibodies: differential myelomonocytic antigen expression of PMA treated HL60 and U937 cell lines.
    Pedrinaci S; Huelin C; Patarroyo M; Ruiz-Cabello F; Garrido F
    Hybridoma; 1989 Feb; 8(1):13-23. PubMed ID: 2564369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxins.
    Engert A; Brown A; Thorpe P
    Leuk Res; 1991; 15(11):1079-86. PubMed ID: 1961012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a leukemia-associated antigen (CAMAL) in peripheral blood leucocytes of bone marrow transplant patients prior to relapse.
    Levy JG; Logan PM; Whitney S; Malcolm AJ; Naiman S; Powles R; Crawford D
    Transplantation; 1985 Aug; 40(2):167-73. PubMed ID: 3895623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of CAMAL-mediated alterations of normal and leukemic in vitro myelopoiesis using inhibitors of proteolytic activity.
    Leitch HA; Levy JG
    Leukemia; 1994 Apr; 8(4):605-11. PubMed ID: 8152256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies to the antigens involving differentiation of myeloid cells in sera from patients with systemic lupus erythematosus.
    Kitagawa H; Hoshino T
    Immunol Lett; 1989 Jun; 21(3):227-35. PubMed ID: 2767724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.
    Jurcic JG; Caron PC; Nikula TK; Papadopoulos EB; Finn RD; Gansow OA; Miller WH; Geerlings MW; Warrell RP; Larson SM
    Cancer Res; 1995 Dec; 55(23 Suppl):5908s-5910s. PubMed ID: 7493368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
    Dawson MJ; Trapani JA
    J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
    Tanimoto M; Scheinberg DA; Cordon-Cardo C; Huie D; Clarkson BD; Old LJ
    Leukemia; 1989 May; 3(5):339-48. PubMed ID: 2716349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.